Carcinoma-associated mucin serum markers CA M26 and CA M29: Efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix
- 21 January 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (2), 170-179
- https://doi.org/10.1002/ijc.2910470203
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Circulating CA 15-3 antigen levels in non-mammary malignanciesBritish Journal of Cancer, 1989
- Bestimmung des SCC-Antigens im Serum von Patientinnen mit ZervixkarzinomGeburtshilfe und Frauenheilkunde, 1987
- Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancerInternational Journal of Cancer, 1987
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.JCI Insight, 1985
- Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumorsInternational Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancerCancer, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981
- Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progressCancer, 1979